罕见！百亿大佬操纵股价，被判三年！

Core Viewpoint - The announcement from Meihua Biological indicates that its controlling shareholder, Meng Qingshan, has been sentenced to three years in prison with a five-year probation for manipulating the securities market, which raises concerns about corporate governance and potential impacts on the company's reputation and operations [1][2]. Group 1: Legal Proceedings - Meng Qingshan was publicly prosecuted in March 2025 and received a criminal judgment in November 2025 for manipulating the securities market, resulting in a three-year prison sentence with a five-year probation and a fine [2][4]. - The case stems from actions taken in 2015, where Meng and another individual manipulated stock prices to avoid losses and fulfill guarantee responsibilities [5][7]. Group 2: Financial Impact - The manipulation led to significant stock price fluctuations, with Meihua Biological's share price increasing from 6.03 yuan to 10.34 yuan, a rise of 71.48%, while the Shanghai Composite Index only increased by 10.81% during the same period [6]. - Following negative news in August 2015, the stock price fell sharply, demonstrating the volatility and risks associated with the manipulated trading activities [6]. Group 3: Regulatory Actions - The China Securities Regulatory Commission (CSRC) determined that Meng and his accomplice had illegal gains totaling 56.5888 million yuan, with fines amounting to 170 million yuan, of which Meng was responsible for 92 million yuan [8].